|
|
|
Vol. 16, No. 3, pp. 301-306, February 1, 2002
1 Department of Pediatric Oncology, Children's Hospital, Dana Farber Cancer Institute, Harvard Medical School, and Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA; 2 Department of Biology, Massachusetts Institute of Technology, and Howard Hughes Medical Institute, Cambridge Massachusetts 02139, USA
| |
ABSTRACT |
|---|
|
|
|---|
Gfi-1 and Gfi-1b are novel proto-oncogenes
identified by retroviral insertional mutagenesis. By gene targeting, we
establish that Gfi-1b is required for the development of two
related blood lineages, erythroid and megakaryocytic, in mice.
Gfi-1b
/
embryonic stem cells fail to contribute
to red cells of adult chimeras. Gfi-1b
/
embryos
exhibit delayed maturation of primitive erythrocytes and subsequently
die with failure to produce definitive enucleated erythrocytes. The
fetal liver of mutant mice contains erythroid and megakaryocytic
precursors arrested in their development. Myelopoiesis is normal.
Therefore, Gfi-1b is an essential transcriptional regulator of
erythroid and megakaryocyte development.
| |
Introduction |
|---|
|
|
|---|
Blood cell formation in vertebrates takes place first in a transient wave in the yolk sac blood islands during the period of primitive (or embryonic) hematopoiesis (embryonic days, E7.5-E11 in the mouse). Definitive (or adult) hematopoiesis, which initially occurs in the fetal liver from ~E11-E18 and then shifts to the bone marrow, sustains blood formation throughout the life of the individual. Definitive hematopoiesis is the product of hematopoietic stem cells (HSCs) that self-renew and also generate progenitors that variously commit to the individual hematopoietic lineages (i.e., erythroid, megakaryocytic, myeloid, and lymphoid).
Commitment of progenitor cells to specific hematopoietic lineages is
controlled in part through the combinatorial action of lineage-restricted and more widely expressed transcription factors (Orkin 2000
). Gene targeting experiments have been pivotal in defining
in vivo requirements of lineage-restricted factors. Loss of single
factors may lead to failure of HSC formation or expansion (Porcher et
al. 1996
; Yamada et al. 1998
), or to defects in specific hematopoietic
lineages (Pevny et al. 1991
; Tsang et al. 1998
). Of note, the majority
of essential hematopoietic transcription factors identified to date are
either genetic targets of chromosomal rearrangements or viral
integration events associated with leukemias or lymphomas (Okuda et al.
1996
; Gilliland 1998
; Rabbitts et al. 1999
).
Insertional mutagenesis with Moloney murine leukemia virus in
c-myc and pim-1 transgenic mice has lead to the
identification of oncogenes capable of collaborating with these
transgenes in lymphomagenesis (van Lohuizen et al. 1991
). Often novel
proto-oncogenes discovered in such experiments turn out to be important
regulators of normal developmental processes, for example,
Bmi-1, a chromatin regulator, crucial for body patterning and
hematopoiesis (van der Lugt et al. 1996
). Another viral integration
site, designated pal-1, was shown to encode Gfi-1, a
gene whose expression was also up-regulated by retroviral insertion in
T-cell lymphoma lines that grew in an IL-2-independent manner (hence,
Gfi for growth factor independent;
Gilks et al. 1993
; Schmidt et al. 1996
; Scheijen et al. 1997
). A
closely related gene product, Gfi-1b, was isolated by sequence
homology (Tong et al. 1998
). Other studies have suggested that
Gfi-1 and Gfi-1b may regulate cell death or cell
cycle programs in cultured cell lines (Grimes et al. 1996b
; Tong et al.
1998
) and that both genes are expressed in hematopoietic tissues (Tong et al. 1998
). Gfi-1 is weakly oncogenic when expressed in
T-lymphoid cells of transgenic mice, and cooperates with c-myc
(Schmidt et al. 1998
). Similarly, Gfi-1b was found to be a
target of proviral integrations in retrovirally induced B cell
lymphomas in Eµ-myc transgenic, pim1/pim2 knockout mice (Tong et al.
1998
). Both Gfi-1 and Gfi-1b have six zinc-fingers,
bind DNA in a sequence-specific manner, and bear a SNAG transcriptional
repression domain (Grimes et al. 1996a
; Zweidler-Mckay et al. 1996
;
Tong et al. 1998
). Interestingly, homologs of Gfi-1/1b in
other organisms like Drosophila and Caenorhabditis elegans also perform important developmental functions. In
Drosophila, the Gfi-1(b)-like senseless gene
is necessary for the development of sensory organs (Nolo et al. 2000
).
In C. elegans, the Gfi-1(b) ortholog pag-3
controls neuroblast cell fate and the identity of its neuronal progeny
(Jia et al. 1996
, 1997
).
As potential oncogenes and critical regulators in diverse developmental contexts, the Gfi-1/1b genes may serve important functions in mammalian development. Through targeted gene disruption of Gfi-1b in mice, we establish that Gfi-1b has an essential role in blood cell development, specifically within the erythroid and megakaryocytic cell lineages.
| |
Results |
|---|
|
|
|---|
Disruption of the Gfi-1b gene is embryonic lethal
Prior studies revealed Gfi-1b expression in spleen and
bone marrow (Grimes et al. 1996b
; Tong et al. 1998
). By Northern blot analysis we observed high-level Gfi-1b expression in erythroid and megakaryocytic cell lines, low-level expression in a myeloid line,
M1, and no detectable expression in lymphoid cells (data not shown).
Our results were consistent with a report describing erythroid-restricted expression of a Gfi-1/1b-like RNA
(accession no. Y10898) in chicken (Fuchs et al. 1997
).
To investigate the function of Gfi-1b in mouse development
and/or hematopoiesis, we disrupted the Gfi-1b gene by
homologous recombination in embryonic stem (ES) cells. Exons 2-4 of
the gene, including the ATG initiator codon in exon 2, were replaced
with a neoR cassette flanked by loxP sites (Fig.
1). Southern blot analysis of
BamHI-digested ES cell DNA with a 3' probe was used to
identify recombinants (Fig. 1B). Proper targeting was confirmed by
long-range PCR from the neoR cassette to 5'
sequences (Fig. 1C). Chimeras were generated and matings were performed
as previously described (Tsang et al. 1998
). Heterozygous
(Gfi-1b+/
) mice appeared normal and were fertile.
Given that Gfi-1b+/
and wild-type mice and embryos
appear to be indistinguishable with respect to all assays that we have
performed so far, we henceforth refer to either genotype as control.
Upon mating of heterozygotes, however, no liveborn
Gfi-1b
/
mice have been observed, whereas
heterozygotes and wild-type offspring were obtained in a ratio of
2:1 (data not shown), indicating embryonic lethality of
Gfi-1b
/
embryos.
|
The phenotypic data presented below were obtained from
Gfi-1b
/
embryos retaining the
neoR gene in the Gfi-1b locus. However, to
rule out phenotypic effects due to the inserted neomycin resistance
marker, we generated mice and embryos lacking the
neoR cassette.
Gfi-1b+/
(
neoR) mice and
Gfi-1b
/
(
neoR) embryos were
indistinguishable from their
Gfi-1b+/
(neoR+) Gfi-1b
/
(neoR+)
counterparts (data not shown). This shows that the phenotype of the
Gfi-1b
/
embryos is not caused by transcriptional
interference of the inserted neoR marker on
neighboring genes (Manis et al. 1998
).
Gfi-1b
/
ES cells fail to contribute to
adult erythropoiesis
In view of the embryonic lethality of homozygotes and prominent
expression in the erythroid lineage, we ascertained whether Gfi-1b is required in a cell-autonomous fashion for production of adult red cells. To this end, Gfi-1b
/
ES
cells were obtained by selection of Gfi-1b+/
ES
cells at increased concentration of G418, and chimeras were generated
by injection into wild-type C57Bl/6 blastocysts. Several high-level
(60%-90%) chimeras were generated as estimated by agouti coat color
contribution of the 129Sv ES cells. We used the difference between
C57Bl/6 and 129Sv-derived hemoglobins to assess the contribution of
ES-derived cells to red cells of adult chimeras. No
Gfi-1b
/
ES-derived contribution to the
hemoglobin of four adult chimeras was detected (Fig.
2, lanes 1-4), whereas
Gfi-1b+/
ES cells contributed readily (Fig. 2B,
lanes 5,6). These experiments suggest that Gfi-1b is required in
a cell-autonomous fashion for red blood cell production.
|
Gfi-1b
/
embryos exhibit abnormal
primitive erythropoiesis
By timed matings of Gfi-1b heterozygotes, we determined
that Gfi-1b
/
embryos die by E15.
Gfi-1b
/
embryos are present at the expected
frequency of 25% at E13.5-E14.5 but were terminal and exhibited
hemorrhage, pallor, and edema suggestive of defects in hematopoiesis
(Fig. 3k). Close examination of blood at
these and earlier stages revealed abnormal primitive erythropoiesis.
Many of the primitive erythrocytes from E9.5-E10.5 Gfi-1b
/
embryos exhibit abnormal morphology
characterized by extensive membrane blebbing and ruffling (Fig. 3d). In
addition, Gfi-1b
/
primitive erythrocytes are
retarded in their overall maturation, as indicated by their less dense
nuclei and more basophilic cytoplasm relative to erythrocytes from
age-matched control embryos (Fig. 3h,l). These results indicate that
Gfi-1b is required for normal primitive erythroid development
and that Gfi-1b
/
embryos die during the
transition from primitive to definitive hematopoiesis.
|
Gfi-1b is required for definitive erythropoiesis
By E14.5 the peripheral blood of wild-type and
Gfi-1b+/
embryos shows a predominance (60%-70%)
of adult enucleated red blood cells, the product of fetal liver
erythropoiesis (Fig. 3j). In contrast, the blood of
Gfi-1b
/
embryos entirely lacks adult red cells
(Fig. 3l). As this indicates a failure of definitive erythropoiesis, we
assessed the stage at which erythropoiesis was arrested in
Gfi-1b
/
fetal livers. We performed FACS analysis
of fetal liver cells doubly stained with antibodies against ter119, a
mouse erythroid-specific marker (Suwabe et al. 1998
), and c-kit, a
marker of immature hematopoietic cells. Whereas fetal liver cells from
wild-type embryos displayed a continuum of cells ranging from
c-kit+ ter119
to
c-kit+ ter119+ to
c-kit
ter119hi, with the
majority of cells (60%-70%) belonging to the latter category (Fig.
4Ab), fetal livers from
Gfi-1b
/
embryos contained roughly equal numbers
of c-kit+ ter119
and
c-kit+ ter119+ cells but very few
c-kit
ter119hi cells (Fig.
4Ad). Hence, Gfi-1b
/
hematopoietic cells commit
to the erythroid lineage (based on their expression of
ter119), but their further development is blocked, as
reflected by continued expression of c-kit. Consistent with
their immature phenotype, fetal livers from
Gfi-1b
/
embryos also showed a relative
enrichment of CD34+ (another marker of hematopoietic
progenitors) cells (data not shown).
|
To confirm that the developmental arrest observed in the
Gfi-1b
/
fetal livers is the consequence of a
cell-intrinsic defect in the hematopoietic progenitors and is not due
to a defective fetal liver environment, we also performed in vitro
colony assays with fetal liver cells from E12.5 embryos. When equal
numbers of cells were plated in methylcellulose medium supplemented
with erythropoietin (epo) and kit ligand (KL), control cells formed
many CFU-Es (colony forming units-erythroid) at day 3 or 4 of culture;
in contrast, very few, if any, CFU-Es were obtained from
Gfi-1b
/
embryos at similar time points (Fig.
4Bd). The few colonies that arose in cultures from
Gfi-1b
/
embryos were markedly paler and
contained only immature erythroid precursors (data not shown).
Beginning at day 4 of culture, rapidly proliferating, dispersed cell
colonies were observed in cultures from Gfi-1b
/
embryos. By day 7, these colonies spread over the entire culture dish
(Fig. 4Be). These colonies were comprised of arrested erythroid progenitors and mast cells, with the latter cell type predominating as
the cultures aged. Cells at this late culture stage (day 7) were
stained with benzidine reagent to identify cells with accumulated hemoglobin. Whereas BFU-Es (erythroid burst-forming units)
obtained from control livers stained positive (Fig. 4Bc),
Gfi-1b
/
cells were negative (Fig. 4Bf).
Therefore, the absence of Gfi-1b leads to a developmental arrest of
erythroid progenitors in the fetal liver at the BFU-E stage or earlier.
Because Gfi-1b is also expressed in a myeloid cell line, M1
(Tong et al. 1998
; data not shown), we evaluated myeloid colony formation of fetal liver cells from Gfi-1b
/
mice. Colony assays in the presence of appropriate cytokines revealed
equivalent numbers of morphologically normal myeloid cells in the fetal
livers of wild-type and Gfi-1b
/
mice (data not
shown). FACS analysis revealed normal numbers of total
Mac-1+/Gr-1+ cells in E12.5 fetal livers (data not
shown). Hence, myeloid development is ostensibly normal in the absence
of Gfi-1b.
Gfi-1b is required for megakaryocyte development
Gfi-1b is highly expressed in megakaryocytic cell lines
(data not shown). Fetal liver cells of wild-type
and Gfi-1b+/
embryos cultured in methylcellulose
media supplemented with the megakaryopoietic cytokine thrombopoietin
(tpo) generate abundant colonies containing large,
acetylcholine-esterase-positive (a mouse megakaryocyte-specific marker)
megakaryocytes (Fig. 5Aa-c). In marked
contrast, Gfi-1b
/
fetal liver cells generate
colonies containing only small acetylcholine-esterase-negative cells
(Fig. 5Ad-f). Consistent with the lack of morphologically mature
megakaryocytes in Gfi-1b
/
fetal liver cultures,
cells from these colonies contained far fewer transcripts for markers
of mature megakaryocytes (Fig. 5B), for example, von-Willebrand factor
(vWF), transcription factor p45/NF-E2, the c-mpl receptor, and
the surface glycoprotein IIb (GpIIb; Shivdasani et al. 1995
). Hence,
loss of Gfi-1b leads to a block in megakaryopoiesis subsequent
to commitment to the megakaryocyte or erythroid/megakaryocytic lineage.
|
| |
Discussion |
|---|
|
|
|---|
We establish here that the zinc-finger transcription factor
Gfi-1b is essential for development of both the erythroid and megakaryocytic cell lineages. Its requirement differs in primitive and
definitive erythropoiesis. Primitive erythroid cells in the yolk sac
develop in the absence of Gfi-1b, but are morphologically abnormal, characterized by membrane blebbing and delayed cellular maturation. Nonetheless, embryos survive to the fetal liver stage, presumably because of adequate oxygen delivery by these primitive red
blood cells. The requirement for Gfi-1b in adult
erythropoiesis, however, is more stringent. In its absence, no
enucleated erythrocytes are produced, and fetal livers are profoundly
deficient in maturing erythroid precursors. Embryos, therefore, succumb
to anemia during the fetal liver stage of development. Differentiation
of megakaryocytes, which are derived from a bipotential
erythroid/megakaryocytic progenitor (Orkin 2000
), is also arrested in
the absence of Gfi-1b. In the absence of Gfi-1b,
presumptive megakaryocytic precursors proliferate in the presence of
thrombopoietin, but fail to mature further. This suggests that
Gfi-1b is required at a point after commitment to the
megakaryocyte lineage. Myeloid development in the absence
of Gfi-1b appears normal. Hence, Gfi-1b joins
GATA-1 and FOG-1, as transcription factors essential
for development of the closely related erythroid and megakaryocytic
lineages (Pevny et al. 1991
; Tsang et al. 1998
).
Gfi-1b in the hierarchy of erythroid/megakaryocytic development
The combined failure of erythroid and megakaryocytic development
in Gfi-1b
/
embryos is reminiscent of the loss of
GATA-1 or FOG-1, factors that act in concert to
program differentiation of these lineages. The relationship, if any, of
Gfi-1b to the regulatory network controlled by
GATA-1/FOG-1 is unknown but worth considering. Gfi-1b might act upstream, downstream, or together with GATA-1/FOG-1 in transcription. We have not observed a significant change in GATA-1 or FOG-1 transcript levels in colonies derived
from Gfi-1b
/
fetal liver cells cultured in
erythropoietin and kit ligand (data not shown). Conversely,
Gfi-1b is expressed in a GATA-1
erythroid cell line (G1E; Weiss et al. 1997
; data not shown). Although
these findings suggest that the proteins are not dependent on each
other for expression, they do not preclude important functional interactions.
Little is known regarding the mechanism of action of Gfi-1b.
Although its binding site has been defined by in vitro PCR selection assays, in vivo gene targets remain unknown. Previously,
Gfi-1b has been proposed to repress the
p21cip1waf1 (p21) gene through a binding
site in its promoter region (Tong et al. 1998
). The relevance of this
observation to hematopoietic development in vivo is uncertain. We have
not detected a significant change in p21 RNA levels in
Gfi-1b
/
fetal liver colonies (data not shown).
Gfi-1b has also been described as a transcriptional repressor
based on the presence of a SNAG domain and in vitro reporter assays
(Zweidler-Mckay et al. 1996
). However, definitive experiments regarding
the function of the SNAG repression domain remain to be performed.
Ectopic expression of Gfi-1b in CD34+ human
progenitor cells augments erythroid cell maturation, and this effect is
not dependent on the presence of the SNAG domain (A. Iwama, pers.
comm.). Hence, repression of transcription mediated by the SNAG domains
may not be the only, or indeed the principal, mode of action of
Gfi-1b in erythroid development.
Gfi-1-related proteins as developmental regulators
The mammalian protein Gfi-1b, like its orthologs in
Drosophila and C. elegans, Senseless and
PAG-3 respectively, regulates the development of specific
cellular lineages (Jia et al. 1996
, 1997
; Nolo et al. 2000
). The three
proteins also show similar DNA-binding specificities consistent with
>80% sequence identity between their DNA-binding zinc fingers, and
presumably have similar target sites in vivo. However, whether they
regulate analogous target genes and pathways in vivo remains to be
elucidated. Notably, both PAG-3 and Senseless lack
the SNAG repression domain, and this structural variation could lead to
mechanistic differences between them in regulating their targets. The
control of sensory organ development in Drosophila by an
autoregulatory loop comprised of senseless and the
basic-helix-loop-helix (bHLH) proneural genes daughterless,
achaete-scute, and atonal (Nolo et al. 2000
) raises the possibility that Gfi-1b may also interact in a
transcriptional network with bHLH factors, within or outside the
hematopoietic system. A likely candidate within the hematopoietic
system is the bHLH factor SCL/tal-1, a gene required for
development of all hematopoietic lineages (Porcher et al. 1996
).
Because loss of Gfi-1b did not affect SCL/tal-1
expression in fetal liver colonies (data not shown), we conclude that
Gfi-1b is not required for SCL expression. Whether
SCL regulates Gfi-1b expression is unknown.
Interestingly, Drosophila counterparts of GATA-1 and
FOG, pannier and u-shaped, respectively,
also play unique roles in the formation of a subset of sensory organs,
the sensory hair bristles. They do so by reciprocally regulating the
genes for achaete and scute (Cubadda et al. 1997
;
Haenlin et al. 1997
). u-shaped and another Drosophila
GATA homolog serpent also function coordinately in hemocyte (a
primitive hematopoietic cell in flies) development (Fossett et al.
2001
), although so far neither senseless nor other Gfi-1 homologs have been implicated in this lineage. Important parallels may therefore exist between Drosophila sensory organ and hemocyte development and mammalian hematopoiesis that merit further investigation.
In conclusion, we have established that the zinc-finger transcription factor Gfi-1b, a proto-oncogene able to cooperate with other oncogenes in lymphomagenesis, is essential for the differentiation of the definitive erythroid and megakaryocytic lineages. Its requirement raises important questions regarding the position of Gfi-1b within the hierarchy of hematopoietic transcription factors, and particularly its functional relationship to GATA-1 and FOG-1, previously identified critical regulatory components in these related lineages.
| |
Materials and methods |
|---|
|
|
|---|
Targeted disruption of the murine Gfi-1b gene
Gfi-1b genomic clones were isolated from a
FixII
mouse strain 129Sv library (Stratagene). Exon/intron structure was
determined by restriction enzyme mapping, PCR, and DNA sequencing. The
targeting construct (Fig. 2A) contained 5.5-kb 5' and 2.8-kb 3'
homology segments flanking a floxed neoR cassette and a
thymidine kinase gene in the vector pLNTK (Gao et al. 1998
). The
construct was linearized with PvuI and electroporated into CJ7
mouse ES cells. Transfectants were selected in G418 (280 µg/mL) and
gancyclovir (2 µM) and expanded for Southern blot analysis and PCR.
The targeting frequency was ~2%. A targeted clone was injected into
C57Bl/6 blastocysts to generate chimeras for germ-line transmission.
Generation of Gfi-1b
/
ES cell and
chimera analysis
Gfi-1b+/
ES cells were passaged on
gelatin-treated plates (Weiss et al. 1994
) and selected at elevated
concentrations (1-2.5 mg/mL) of G418 (Mortensen et al. 1992
). Clones
viable at concentrations of 1.9-2.0 mg/mL of G418 were subjected to
Southern blot analysis to identify homozygous mutants. Hemoglobin analysis of
chimeras was performed as previously described (Pevny et al. 1991
).
Histology and cytology
Cytocentrifuge preparations were stained with
May-Grunwald-Giemsa for general morphology. Benzidine staining and
acetylcholine esterase assays were performed by standard methods (Tsang
et al. 1998
).
In vitro hematopoietic colony assays
E10.5-E12.5 fetal livers were dissected under sterile
conditions. Cells were disaggregated (Wong et al. 1986
) and plated in methylcellulose media containing 30% FCS (Stem cell Technologies), supplemented with one or more of the following cytokines: Epo (2 U/mL),
rat KL (50 ng/mL), recombinant human Tpo (1% v/v of a cell culture
supernatant; Villeval et al. 1997
).
Flow cytometry
E12.5 fetal liver cells were disaggregated, stained with fluorochrome-labeled antibodies, and scanned in a FACScalibur flow cytometer (Becton Dickinson). The presence of appropriate markers was examined either in the entire cell population or in subpopulations gated according to their forward scatter (size) or side scatter (granularity).
Semiquantitative RT-PCR
Total RNA was prepared from pooled fetal liver colonies using
the RNeasy kit (QIAGEN), then 100 ng of total RNA was used as the
template in a one-step RT-PCR reaction (QIAGEN) with previously described megakaryocyte-specific and HPRT primers (Tsang et al. 1998
).
Aliquots were withdrawn at 24, 26, 28, and 30 cycles of PCR and
examined on an agarose gel.
| |
Acknowledgments |
|---|
We thank Carol Browne for invaluable assistance in ES cell culture and Yuko Fujiwara, Aimee Williams, and Shelly Galusha for generation of chimeric mice. S.S. is a Research Associate of the HHMI. S.H.O. is an Investigator of the HHMI.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
[Key Words: Transcription factor; hematopoiesis; development; oncogene]
Received November 1, 2001; revised version accepted December 6, 2001.
3 Present address: Department of Pediatrics and of Molecular Biology and Oncology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.
4 Corresponding author.
E-MAIL stuart_orkin{at}dfci.harvard.edu; FAX (617) 738-5922.
Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.959102.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. J. Chyla, I. Moreno-Miralles, M. A. Steapleton, M. A. Thompson, S. Bhaskara, M. Engel, and S. W. Hiebert Deletion of Mtg16, a Target of t(16;21), Alters Hematopoietic Progenitor Cell Proliferation and Lineage Allocation Mol. Cell. Biol., October 15, 2008; 28(20): 6234 - 6247. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Frontelo, D. Manwani, M. Galdass, H. Karsunky, F. Lohmann, P. G. Gallagher, and J. J. Bieker Novel role for EKLF in megakaryocyte lineage commitment Blood, December 1, 2007; 110(12): 3871 - 3880. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. F. Marteijn, L. T. van der Meer, L. van Emst, S. van Reijmersdal, W. Wissink, T. de Witte, J. H. Jansen, and B. A. Van der Reijden Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1 Blood, November 1, 2007; 110(9): 3128 - 3135. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ayyanathan, H. Peng, Z. Hou, W. J. Fredericks, R. K. Goyal, E. M. Langer, G. D. Longmore, and F. J. Rauscher III The Ajuba LIM Domain Protein Is a Corepressor for SNAG Domain Mediated Repression and Participates in Nucleocytoplasmic Shuttling Cancer Res., October 1, 2007; 67(19): 9097 - 9106. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Kuo and Z.-F. Chang GATA-1 and Gfi-1B Interplay To Regulate Bcl-xL Transcription Mol. Cell. Biol., June 15, 2007; 27(12): 4261 - 4272. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xu and B. L. Kee Growth factor independent 1B (Gfi1b) is an E2A target gene that modulates Gata3 in T-cell lymphomas Blood, May 15, 2007; 109(10): 4406 - 4414. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vassen, T. Okayama, and T. Moroy Gfi1b:green fluorescent protein knock-in mice reveal a dynamic expression pattern of Gfi1b during hematopoiesis that is largely complementary to Gfi1 Blood, March 15, 2007; 109(6): 2356 - 2364. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. F. Marteijn, L. T. van der Meer, L. Van Emst, T. de Witte, J. H. Jansen, and B. A. van der Reijden Diminished proteasomal degradation results in accumulation of Gfi1 protein in monocytes Blood, January 1, 2007; 109(1): 100 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhu, D. Jankovic, A. Grinberg, L. Guo, and W. E. Paul Gfi-1 plays an important role in IL-2-mediated Th2 cell expansion PNAS, November 28, 2006; 103(48): 18214 - 18219. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hosoya-Ohmura, N. Mochizuki, M. Suzuki, O. Ohneda, K. Ohneda, and M. Yamamoto GATA-4 Incompletely Substitutes for GATA-1 in Promoting Both Primitive and Definitive Erythropoiesis in Vivo J. Biol. Chem., October 27, 2006; 281(43): 32820 - 32830. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bose, C. Fugazza, M. Casalgrandi, A. Capelli, J. M. Cunningham, Q. Zhao, S. M. Jane, S. Ottolenghi, and A. Ronchi Functional Interaction of CP2 with GATA-1 in the Regulation of Erythroid Promoters Mol. Cell. Biol., May 15, 2006; 26(10): 3942 - 3954. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Acar, H. Jafar-Nejad, N. Giagtzoglou, S. Yallampalli, G. David, Y. He, C. Delidakis, and H. J. Bellen Senseless physically interacts with proneural proteins and functions as a transcriptional co-activator Development, May 15, 2006; 133(10): 1979 - 1989. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ito, N. Arimitsu, M. Takeuchi, N. Kawamura, M. Nagata, K. Saso, N. Akimitsu, H. Hamamoto, S. Natori, A. Miyajima, et al. Transcription Elongation Factor S-II Is Required for Definitive Hematopoiesis Mol. Cell. Biol., April 15, 2006; 26(8): 3194 - 3203. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Schuh, A. J. Tipping, A. J. Clark, I. Hamlett, B. Guyot, F. J. Iborra, P. Rodriguez, J. Strouboulis, T. Enver, P. Vyas, et al. ETO-2 Associates with SCL in Erythroid Cells and Megakaryocytes and Provides Repressor Functions in Erythropoiesis Mol. Cell. Biol., December 1, 2005; 25(23): 10235 - 10250. [Abstract] [Full Text] [PDF] |
||||
![]() |
|